Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonates

Clinical trial NCT02806141 · TERMINATED

Trial details

NCT number: NCT02806141
Sponsor: Hat Yai Medical Education Center
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumonia, Ventilator-Associated Colistin Adverse Reaction Infection Due to Multidrug Resistant Acinetobacter Infection Resistant to Multiple Drugs

Start date: 2016-09-01
Primary completion: 2017-10-01
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.